Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
American Journal of Human Genetics
|
July 13, 2000
The disequilibrium maximum-likelihood-binomial test does not replace the transmission/disequilibrium test
S Horvath, C Windemuth, M Knapp
Animal Genetics
|
January 12, 1999
Fitting genetic mapping functions based on sperm typing: results for three chromosomal segments in cattle
C Windemuth, H Simianer, S Lien
Immunology Letters
|
July 27, 2001
Peripheral blood cell bulk cultures are not suitable for the analysis of the genetic control of T-cell cytokine function
F Zipp, C Windemuth, J Dichgans, et al.
Genetic Epidemiology
|
December 22, 1999
Linkage analysis in alcohol dependence
C Windemuth, A Hahn, K Strauch, et al.
Genetic Epidemiology
|
December 22, 1999
Linkage analysis with adequate modeling of a parent-of-origin effect
K Strauch, R Fimmers, C Windemuth, et al.
Human Immunology
|
November 18, 2000
Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2
F Zipp, C Windemuth, H Pankow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2013
The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer
P Hadji, M Blettner, N Harbeck, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 12, 2014
Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network
Karin Hohloch, H K Lankeit, P L Zinzani, et al.
Clinical and Translational Radiation Oncology
|
October 30, 2018
Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx
H Hauswald, A D Jensen, J Krauss, et al.
Bone Marrow Transplantation
|
September 28, 2010
Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network
K Hohloch, P L Zinzani, W Linkesch, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
American Journal of Human Genetics
|
July 13, 2000
The disequilibrium maximum-likelihood-binomial test does not replace the transmission/disequilibrium test
S Horvath, C Windemuth, M Knapp
Animal Genetics
|
January 12, 1999
Fitting genetic mapping functions based on sperm typing: results for three chromosomal segments in cattle
C Windemuth, H Simianer, S Lien
Immunology Letters
|
July 27, 2001
Peripheral blood cell bulk cultures are not suitable for the analysis of the genetic control of T-cell cytokine function
F Zipp, C Windemuth, J Dichgans, et al.
Genetic Epidemiology
|
December 22, 1999
Linkage analysis in alcohol dependence
C Windemuth, A Hahn, K Strauch, et al.
Genetic Epidemiology
|
December 22, 1999
Linkage analysis with adequate modeling of a parent-of-origin effect
K Strauch, R Fimmers, C Windemuth, et al.
Human Immunology
|
November 18, 2000
Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2
F Zipp, C Windemuth, H Pankow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2013
The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer
P Hadji, M Blettner, N Harbeck, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 12, 2014
Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network
Karin Hohloch, H K Lankeit, P L Zinzani, et al.
Clinical and Translational Radiation Oncology
|
October 30, 2018
Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx
H Hauswald, A D Jensen, J Krauss, et al.
Bone Marrow Transplantation
|
September 28, 2010
Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network
K Hohloch, P L Zinzani, W Linkesch, et al.
Page
of 3